Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit
Johnson & Johnson · PHARMACEUTICAL PREPARATIONS · Now $225.33
-2.0% in 7d after detection
Post-detection moves
1h
—
1d
-0.3%
3d
+1.9%
7d
-2.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS